海晨股份(300873.SZ):回購方案實施完畢、已累計回購194.2萬股
格隆匯7月12日丨海晨股份(300873.SZ)公佈,2022年7月12日,公司召開了第三屆董事會第三次會議,審議通過了《關於回購股份期限提前屆滿暨回購方案實施完畢的議案》。鑑於公司回購金額已達到此次回購方案中回購金額下限,結合公司總體資金安排、近期股價走勢以及公司向特定對象發行股份的進度,同意提前完成此次回購,此次回購方案實施完畢。
截至2022年7月11日,公司通過股票回購專用賬户以集中競價方式實施回購公司股份累計194.2萬股,佔公司總股本的0.91%,最高成交價為27.24元/股,最低成交價為23.67元/股,成交總金額為5005.52萬元(不含交易費用)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.